The cohorts included two types of controls, the healthy controls as well as asymptomatic individuals that are carriers of PD‐associated mutation G2019S LRRK2. The cohorts also included PD patients with and without the mutation, and patients of both sexes, thus allowing for different types of comparisons. The gene discussed is LRRK2; the disease is Parkinson disease.